https://www.selleckchem.com/products/gw6471.html
orticosteroid therapy, and pembrolizumab was restarted with the aid of STTA. As ocular irAEs might be controlled by local corticosteroid therapy, the decision to continue immune checkpoint inhibitor therapy should be made on a case-by-case basis. To describe a unique case of unilateral benign yellow dot maculopathy. A 25-year-man was evaluated after incidental finding of yellow dots in the right macula. The findings of examination and multimodal imaging were in keeping with a diagnosis of benign yellow dot maculopathy. Benign yellow dot
Like
Comment
Share
